University of Sheffield and Rinri Therapeutics, United Kingdom
Marcelo Rivolta qualified in Medicine and Surgery at the National University of Cordoba, Argentina and did his fellowship and doctoral work at the NIH in the USA. He held postdoctoral positions in the USA and UK, and is now Chair of Sensory Stem Cell Biology at the University of Sheffield. For the last two decades his lab has focussed on developing regenerative strategies for the inner ear.
In the late nineties did pioneering work culturing auditory progenitors from the mouse cochlea. Later, his lab identified and isolated a similar population from the human foetal cochlea. He also generated one of the first developmentally informed protocols to direct human pluripotent stem cells into auditory cell types and established the proof of concept that stem cell-derived otic progenitors can be used to functionally repair the damaged cochlea.
To advance the clinical application of this work, in 2018 he founded Rinri Therapeutics, and is currently Rinri’s Chief Scientific Officer.
Friday, June 13, 2025
9:25 AM – 9:35 AM HK Time
CLINICAL TRANSLATION OF BIOENGINEERED TISSUE-BASED THERAPEUTICS
Friday, June 13, 2025
8:30 AM – 10:00 AM HK Time